{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001766","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2025-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.945648+00:00","generated_at":"2026-05-17T05:05:30.590239+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Artelo Biosciences closes $2M public offering of common stock and pre-funded warrants","bullets":["Gross proceeds ~$2M from 441,210 shares at $4.40/share and 13,335 pre-funded warrants at $4.399/warrant (ex. price $0.001).","Underwriter R.F. Lafferty has 45-day option to purchase up to additional 68,181 shares/warrants for overallotments.","Net proceeds will advance preclinical/clinical development, manufacturing, and working capital needs.","Directors, officers subject to 30-day lock-up; company granted R.F. Lafferty right of first refusal through Dec 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001766","json":"https://secwatch.observer/filing/0001640334-25-001766.json","markdown":"https://secwatch.observer/filing/0001640334-25-001766.md","text":"https://secwatch.observer/filing/0001640334-25-001766.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001766/0001640334-25-001766-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001766/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:05:30.590239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}